SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-055935
Filing Date
2024-03-01
Accepted
2024-03-01 16:07:02
Documents
18
Period of Report
2024-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d773342d8k.htm   iXBRL 8-K 37602
2 EX-10.1 d773342dex101.htm EX-10.1 280990
3 EX-10.2 d773342dex102.htm EX-10.2 203953
4 EX-99.1 d773342dex991.htm EX-99.1 10059
8 GRAPHIC g773342g0228215350079.jpg GRAPHIC 3356
  Complete submission text file 0001193125-24-055935.txt   766859

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA crnx-20240227.xsd EX-101.SCH 2855
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20240227_lab.xml EX-101.LAB 17234
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20240227_pre.xml EX-101.PRE 10815
19 EXTRACTED XBRL INSTANCE DOCUMENT d773342d8k_htm.xml XML 3510
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 24709651
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)